Cerus (CERS) Tops Q3 EPS by 3c ; Offers Guidance
Tweet
Share
E-mailGet Alerts CERS Hot Sheet
Price: $2.84 +4.80%
Financial Fact:
Cost of product revenue: 5.45M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Cost of product revenue: 5.45M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Cerus (NASDAQ: CERS) reported Q3 EPS of $0.00, $0.03 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $60.2 million versus the consensus estimate of $57.7 million.
GUIDANCE:
Cerus sees FY2025 revenue of $202-204 million, versus the consensus of $218.6 million.
For earnings history and earnings-related data on Cerus (CERS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Silver Lake In Talks To Buy Workday, Sources Say - Reuters
- Omega Flex (OFLX) Tops Q2 EPS by 27c
- Jefferies sees a buying opportunity in this S&P 500 sector
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
